Abou-Sleiman, P. M., Muqit, M. M. K., & Wood, N. W. (2006). Expanding insights of mitochondrial dysfunction in Parkinson’s disease. Nature Reviews Neuroscience, 7(3), 207–219. https://doi.org/10.1038/nrn1868
Altshuler, D., Daly, M. J., & Lander, E. S. (2008). Genetic Mapping in Human Disease. Science, 322(5903), 881–888. https://doi.org/10.1126/science.1156409
Antonarakis, S. E., & Beckmann, J. S. (2006). Mendelian disorders deserve more attention. Nature Reviews Genetics, 7(4), 277–282. https://doi.org/10.1038/nrg1826
Atherosclerosis — An Inflammatory Disease — NEJM. (n.d.).
Balding, D. J. (2006). A tutorial on statistical methods for population association studies. Nature Reviews Genetics, 7(10), 781–791. https://doi.org/10.1038/nrg1916
Bishop, M., Cannings, C., & Balding, D. J. (2007). Handbook of statistical genetics (3rd ed). John Wiley. https://onlinelibrary.wiley.com/doi/book/10.1002/9781119487845
Botstein, D., & Risch, N. (2003). Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genetics, 33(3s), 228–237. https://doi.org/10.1038/ng1090
Bras, J. M., & Singleton, A. (2009). Genetic susceptibility in Parkinson’s disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1792(7), 597–603. https://doi.org/10.1016/j.bbadis.2008.11.008
Brinkman, R. R., Dubé, M.-P., Rouleau, G. A., Orr, A. C., & Samuels, M. E. (2006). Human monogenic disorders — a source of novel drug targets. Nature Reviews Genetics, 7(4), 249–260. https://doi.org/10.1038/nrg1828
Burton, Paul, Palmer, Lyle, & Smith, George Davey. (2011). An introduction to genetic epidemiology: Vol. Health&society series. Policy Press.
Capecchi, M. R. (2005). Essay: Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nature Reviews Genetics, 6(6), 507–512. https://doi.org/10.1038/nrg1619
Daly, A. K. (2010). Genome-wide association studies in pharmacogenomics. Nature Reviews Genetics, 11(4), 241–246. https://doi.org/10.1038/nrg2751
Foulkes, Andrea S. (2009). Applied statistical genetics with R: for population-based association studies: Vol. Use R! Springer. https://doi.org/10.1007/978-0-387-89554-3
Gibb, Alasdair J., Foreman, John C., & Johansen, Torben. (2011). Textbook of receptor pharmacology (3rd ed). CRC Press. https://doi.org/10.1201/9781420052558
Hall, I. P., & Pirmohamed, M. (2006). Pharmacogenetics. Taylor & Francis. https://doi.org/10.3109/9781420016697
Hansson, G. K., & Libby, P. (2006). The immune response in atherosclerosis: a double-edged sword. Nature Reviews Immunology, 6(7), 508–519. https://doi.org/10.1038/nri1882
Hirschhorn, J. N., & Daly, M. J. (2005). Genome-wide association studies for common diseases and complex traits. Nature Reviews Genetics, 6(2), 95–108. https://doi.org/10.1038/nrg1521
Holmes, M. V. (2011). CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular EventsA Systematic Review and Meta-analysis. JAMA: The Journal of the American Medical Association, 306(24). https://doi.org/10.1001/jama.2011.1880
Holmes, M. V., Shah, T., Vickery, C., Smeeth, L., Hingorani, A. D., & Casas, J. P. (2009a). Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies. PLoS ONE, 4(12). https://doi.org/10.1371/journal.pone.0007960
Holmes, M. V., Shah, T., Vickery, C., Smeeth, L., Hingorani, A. D., & Casas, J. P. (2009b). Fulfilling the Promise of Personalized Medicine? Systematic Review and Field Synopsis of Pharmacogenetic Studies. PLoS ONE, 4(12). https://doi.org/10.1371/journal.pone.0007960
Humphries, S. E., & Hingorani, A. (2006). Pharmacogenetics: Progress, pitfalls and clinical potential for coronary heart disease. Vascular Pharmacology, 44(2), 119–125. https://doi.org/10.1016/j.vph.2005.10.003
Kathiresan, S., Voight, B. F., Purcell, S., Musunuru, K., Ardissino, D., Mannucci, P. M., Anand, S., Engert, J. C., Samani, N. J., Schunkert, H., Erdmann, J., Reilly, M. P., Rader, D. J., Morgan, T., Spertus, J. A., Stoll, M., Girelli, D., McKeown, P. P., Patterson, C. C., … Elosua, R. (2009). Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature Genetics, 41(3), 334–341. https://doi.org/10.1038/ng.327
Kenakin, Terrence P. (2009). A pharmacology primer: theory, applications, and methods (3rd ed). Elsevier Academic Press. https://www-sciencedirect-com.libproxy.ucl.ac.uk/book/9780123745859/a-pharmacology-primer
Kirkwood, Betty R., Kirkwood, Betty R., & Sterne, Jonathan A. C. (2003). Essential medical statistics (2nd ed). Blackwell Science.
Lee, A. J. X., & Swanton, C. (2012). Tumour heterogeneity and drug resistance: Personalising cancer medicine through functional genomics. Biochemical Pharmacology, 83(8), 1013–1020. https://doi.org/10.1016/j.bcp.2011.12.008
Lefkowitz, R. J. (2004). Historical review: A brief history and personal retrospective of seven-transmembrane receptors. Trends in Pharmacological Sciences, 25(8), 413–422. https://doi.org/10.1016/j.tips.2004.06.006
Lesk, Arthur M. (2008). Introduction to bioinformatics (3rd ed). Oxford University Press.
McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nature Reviews Genetics, 9(5), 356–369. https://doi.org/10.1038/nrg2344
Neale, Benjamin M. & International Workshop of Twin and Family Studies. (2008). Statistical genetics: gene mapping through linkage and association. Taylor & Francis.
Neubig, R. R. (2003). International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology. Pharmacological Reviews, 55(4), 597–606. https://doi.org/10.1124/pr.55.4.4
New Perspectives for the Elucidation of Genetic Disorders. (n.d.). https://doi.org/520679
O’Connor, T. P., & Crystal, R. G. (2006). Genetic medicines: treatment strategies for hereditary disorders. Nature Reviews Genetics, 7(4), 261–276. https://doi.org/10.1038/nrg1829
Orengo, Christine Ann, Jones, David Tudor, & Thornton, Janet M. (2003). Bioinformatics: genes, proteins and computers. BIOS. https://www.vlebooks.com/Product/Index/2052147?page=0&startBookmarkId=-1
Ropers, H.-H. (2007). New Perspectives for the Elucidation of Genetic Disorders. The American Journal of Human Genetics, 81(2), 199–207. https://doi.org/10.1086/520679
Seifert, R., & Wenzel-Seifert, K. (2002). Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg’s Archives of Pharmacology, 366(5), 381–416. https://doi.org/10.1007/s00210-002-0588-0
Sham, P. (2007). Statistics in human genetics. Wiley.
Table of contents : Nature Reviews Genetics Focus on Monogenic disorders. (n.d.).
Thomas, Duncan C. (2004). Statistical methods in genetic epidemiology. Oxford University Press.
Thompson, A. J., Lester, H. A., & Lummis, S. C. R. (2010). The structural basis of function in Cys-loop receptors. Quarterly Reviews of Biophysics, 43(04), 449–499. https://doi.org/10.1017/S0033583510000168
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., & Lisheng, L. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 364(9438), 937–952. https://doi.org/10.1016/S0140-6736(04)17018-9
Zvelebil, Marketa J. & Baum, Jeremy O. (2008). Understanding bioinformatics. Garland Science. https://bibliu.com/app/#/view/books/9781136976964/pdf2htmlex/index.html#page_Cover